Clinical Trial Update: Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for favipiravir tablets combined with chloroquine phosphate in the treatment of Novel Coronavirus Pneumonia (Phase 2 and Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Novel Coronavirus Pneumonia

Drugs mentioned

• Chloroquine phosphate (Chloroquine phosphate)
• Favipiravir (favipiravir)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Novel Coronavirus Pnuemonia | Phase 2, Phase 3 | Status: UNKNOWN